N/A
Manufactured by Bausch & Lomb Incorporated
16,822 FDA adverse event reports analyzed
Last updated: 2026-04-14
TIMOLOL MALEATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Bausch & Lomb Incorporated. The most commonly reported adverse reactions for TIMOLOL MALEATE include TREATMENT FAILURE, DRUG INEFFECTIVE, EYE PAIN, FATIGUE, EYE IRRITATION. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for TIMOLOL MALEATE.
Out of 9,568 classified reports for TIMOLOL MALEATE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 16,822 FDA FAERS reports that mention TIMOLOL MALEATE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include TREATMENT FAILURE, DRUG INEFFECTIVE, EYE PAIN, FATIGUE, EYE IRRITATION, DIZZINESS. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Bausch & Lomb Incorporated in connection with TIMOLOL MALEATE. Always verify the specific product and NDC with your pharmacist.